Search Results - "Seferović, Petar"

Treatment of cardiac transthyretin amyloidosis: an update by Emdin, Michele, Aimo, Alberto, Rapezzi, Claudio, Fontana, Marianna, Perfetto, Federico, Seferović, Petar M, Barison, Andrea, Castiglione, Vincenzo, Vergaro, Giuseppe, Giannoni, Alberto, Passino, Claudio, Merlini, Giampaolo

“…Abstract Transthyretin (TTR) is a tetrameric protein synthesized mostly by the liver. As a result of gene mutations or as an ageing-related phenomenon, TTR…”
Get full text

2018 ESC/EACTS Guidelines on myocardial revascularization by Neumann, Franz-Josef, Sousa-Uva, Miguel, Ahlsson, Anders, Alfonso, Fernando, Banning, Adrian P., Benedetto, Umberto, Byrne, Robert A., Collet, Jean-Philippe, Falk, Volkmar, Head, Stuart J., Jüni, Peter, Kastrati, Adnan, Koller, Akos, Kristensen, Steen D., Niebauer, Josef, Richter, Dimitrios J., Seferović, Petar M., Sibbing, Dirk, Stefanini, Giulio G., Windecker, Stephan, Yadav, Rashmi, Zembala, Michael O.

Get full text

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy by Seferović, Petar M., Tsutsui, Hiroyuki, McNamara, Dennis M., Ristić, Arsen D., Basso, Cristina, Bozkurt, Biykem, Cooper, Leslie T., Filippatos, Gerasimos, Ide, Tomomi, Inomata, Takayuki, Klingel, Karin, Linhart, Aleš, Lyon, Alexander R., Mehra, Mandeep R., Polovina, Marija, Milinković, Ivan, Nakamura, Kazufumi, Anker, Stefan D., Veljić, Ivana, Ohtani, Tomohito, Okumura, Takahiro, Thum, Thomas, Tschöpe, Carsten, Rosano, Giuseppe, Coats, Andrew J.S., Starling, Randall C.

“…Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant (HTx) rejection. In addition, EMB can…”
Get full text

Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology by Corrà, Ugo, Agostoni, Pier Giuseppe, Anker, Stefan D., Coats, Andrew J.S., Crespo Leiro, Maria G., de Boer, Rudolph A., Harjola, Veli‐Pekka, Hill, Loreena, Lainscak, Mitja, Lund, Lars H., Metra, Marco, Ponikowski, Piotr, Riley, Jillian, Seferović, Petar M., Piepoli, Massimo F.

“…Traditionally, the main indication for cardiopulmonary exercise testing (CPET) in heart failure (HF) was for the selection of candidates to heart…”
Get full text

The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019 by Seferović, Petar M., Vardas, Panagiotis, Jankowska, Ewa A., Maggioni, Aldo P., Timmis, Adam, Milinković, Ivan, Polovina, Marija, Gale, Chris P., Lund, Lars H., Lopatin, Yuri, Lainscak, Mitja, Savarese, Gianluigi, Huculeci, Radu, Kazakiewicz, Dzianis, Coats, Andrew J.S.

“…Aims The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) developed the HFA Atlas to provide a contemporary description of heart…”
Get full text

Metabolic dysfunction: An important driver of incident heart failure with preserved and reduced ejection fraction by Ostrominski, John W., Seferović, Petar M., Selvaraj, Senthil

Get full text

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management by Ceriello, Antonio, Catrinoiu, Doina, Chandramouli, Chanchal, Cosentino, Francesco, Dombrowsky, Annique Cornelia, Itzhak, Baruch, Lalic, Nebojsa Malić, Prattichizzo, Francesco, Schnell, Oliver, Seferović, Petar M., Valensi, Paul, Standl, Eberhard

“…Abstract Type 2 diabetes is one of the most relevant risk factors for heart failure, the prevalence of which is increasing worldwide. The aim of the review is…”
Get full text

European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure by Seferović, Petar M., Coats, Andrew J.S., Ponikowski, Piotr, Filippatos, Gerasimos, Huelsmann, Martin, Jhund, Pardeep S., Polovina, Marija M., Komajda, Michel, Seferović, Jelena, Sari, Ibrahim, Cosentino, Francesco, Ambrosio, Giuseppe, Metra, Marco, Piepoli, Massimo, Chioncel, Ovidiu, Lund, Lars H., Thum, Thomas, De Boer, Rudolf A., Mullens, Wilfried, Lopatin, Yuri, Volterrani, Maurizio, Hill, Loreena, Bauersachs, Johann, Lyon, Alexander, Petrie, Mark C., Anker, Stefan, Rosano, Giuseppe M.C.

“…ABSTRACT Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and associated with considerable morbidity and mortality. Significant…”
Get full text

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure by Bozkurt, Biykem, Coats, Andrew J.S., Tsutsui, Hiroyuki, Abdelhamid, Ca Magdy, Adamopoulos, Stamatis, Albert, Nancy, Anker, Stefan D., Atherton, John, Böhm, Michael, Butler, Javed, Drazner, Mark H., Michael Felker, G., Filippatos, Gerasimos, Fiuzat, Mona, Fonarow, Gregg C., Gomez‐Mesa, Juan‐Esteban, Heidenreich, Paul, Imamura, Teruhiko, Jankowska, Ewa A., Januzzi, James, Khazanie, Prateeti, Kinugawa, Koichiro, Lam, Carolyn S.P., Matsue, Yuya, Metra, Marco, Ohtani, Tomohito, Francesco Piepoli, Massimo, Ponikowski, Piotr, Rosano, Giuseppe M.C., Sakata, Yasushi, Seferović, Petar, Starling, Randall C., Teerlink, John R., Vardeny, Orly, Yamamoto, Kazuhiro, Yancy, Clyde, Zhang, Jian, Zieroth, Shelley

“…In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or…”
Get full text

Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology by Seferović, Petar M., Fragasso, Gabriele, Petrie, Mark, Mullens, Wilfried, Ferrari, Roberto, Thum, Thomas, Bauersachs, Johann, Anker, Stefan D., Ray, Robin, Çavuşoğlu, Yuksel, Polovina, Marija, Metra, Marco, Ambrosio, Giuseppe, Prasad, Krishna, Seferović, Jelena, Jhund, Pardeep S., Dattilo, Giuseppe, Čelutkiene, Jelena, Piepoli, Massimo, Moura, Brenda, Chioncel, Ovidiu, Ben Gal, Tuvia, Heymans, Stefan, Boer, Rudolf A., Jaarsma, Tiny, Hill, Loreena, Lopatin, Yuri, Lyon, Alexander R., Ponikowski, Piotr, Lainščak, Mitja, Jankowska, Ewa, Mueller, Christian, Cosentino, Francesco, Lund, Lars, Filippatos, Gerasimos S., Ruschitzka, Frank, Coats, Andrew J.S., Rosano, Giuseppe M.C.

“…Heart failure (HF) is common and associated with a poor prognosis, despite advances in treatment. Over the last decade cardiovascular outcome trials with…”
Get full text

Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes by Davies, Melanie J., Drexel, Heinz, Jornayvaz, François R., Pataky, Zoltan, Seferović, Petar M., Wanner, Christoph

“…Abstract Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with type 2 diabetes (T2D). Historical concerns about…”
Get full text

Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC by Corrà, Ugo, Piepoli, Massimo F, Adamopoulos, Stamatis, Agostoni, Piergiuseppe, Coats, Andrew J S, Conraads, Viviane, Lambrinou, Ekaterini, Pieske, Burkert, Piotrowicz, Ewa, Schmid, Jean-Paul, Seferović, Petar M, Anker, Stefan D, Filippatos, Gerasimos, Ponikowski, Piotr P

“…The relationship between exercise capacity, as assessed by peak oxygen consumption, and outcome is well established in heart failure (HF), but the predictive…”
Get full text

In search of a ‘safety zone’ for glycaemic control: association between glycosylated haemoglobin levels and outcomes in patients with type 2 diabetes and cardiovascular disease by Seferović, Petar M., Polovina, Marija

Get full text

Risk stratification models for predicting mortality in heart failure: a favourite or an outsider? by Seferović, Petar, Polovina, Marija, Milinković, Ivan, Krljanac, Gordana, Ašanin, Milika

Get full text

Corrigendum to “Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes” [International Journal of Cardiology 2023 Jan 15;371:293–294 10.1016/j.ijcard.2022.09.019 by Seferović, Petar M., Polovina, Marija, Seferović, Jelena, Rosano, Giuseppe

Get full text

Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure by Seferović, Petar M., Fragasso, Gabriele, Petrie, Mark, Mullens, Wilfried, Ferrari, Roberto, Thum, Thomas, Bauersachs, Johann, Anker, Stefan D., Ray, Robin, Çavuşoğlu, Yuksel, Polovina, Marija, Metra, Marco, Ambrosio, Giuseppe, Prasad, Krishna, Seferović, Jelena, Jhund, Pardeep S., Dattilo, Giuseppe, Čelutkiene, Jelena, Piepoli, Massimo, Moura, Brenda, Chioncel, Ovidiu, Ben Gal, Tuvia, Heymans, Stephane, Jaarsma, Tiny, Hill, Loreena, Lopatin, Yuri, Lyon, Alexander R., Ponikowski, Piotr, Lainščak, Mitja, Jankowska, Ewa, Mueller, Christian, Cosentino, Francesco, Lund, Lars H., Filippatos, Gerasimos S., Ruschitzka, Frank, Coats, Andrew J.S., Rosano, Giuseppe M.C.

“…The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued a position paper on the role of sodium–glucose…”
Get full text

The Heart Failure Association Atlas: rationale, objectives, and methods by Seferović, Petar M., Jankowska, Ewa, Coats, Andrew J.S., Maggioni, Aldo P., Lopatin, Yuri, Milinković, Ivan, Polovina, Marija, Lainščak, Mitja, Timmis, Adam, Huculeci, Radu, Vardas, Panos, Berger, Rudolf, Jahangirov, Tofiq, Kurlianskaya, Alena, Troisfontaines, Pierre, Droogne, Walter, Dizdarević Hudić, Larisa, Tokmakova, Mariya, Glavaš, Duška, Barberis, Vassilis, Spinar, Jindrich, Wolsk, Emil, Uuetoa, Tiina, Tolppanen, Heli, Damy, Thibaud, Kipiani, Zviad, Störk, Stefan, Keramida, Kalliopi, Habon, Tamas, Gotsman, Israel, Weinstein, Jean‐Marc, Jona Ingimarsdottir, Inga, Crowley, Jim, Dalton, Barbra, Aspromonte, Nadia, Rakisheva, Amina, Mirrakhimov, Erkin, Kamzola, Ginta, Skouri, Hadi, Celutkiene, Jelena, Noppe, Stephanie, Jovanova, Silvana, Vataman, Eleonora, Pogorevici Cobac, Irina, Van Pol, Petra, Boer, Rudolf A., von Lueder, Thomas, Straburzyńska‐Migaj, Ewa, Moura, Brenda, Chioncel, Ovidiu, Fomin, Igor, Begrambekova, Julia, Lopatin, Yuri, Mareev, Yuri, Goncalvesova, Eva, Seferović, Petar, Milinković, Ivan, Lainscak, Mitja, Garcia Pinilla, José Manuel, Lindmark, Krister, Ruschitzka, Frank, Mueller, Christian, Cavusoglu, Yuksel, Gardner, Roy, Voronkov, Leonid

“…Heart failure (HF) constitutes the growing cardiovascular burden and the major public health issue, but comprehensive statistics on HF epidemiology and related…”
Get full text

Telerehabilitation in heart failure patients: The evidence and the pitfalls by Piotrowicz, Ewa, Piepoli, Massimo F, Jaarsma, Tiny, Lambrinou, Ekaterini, Coats, Andrew J.S, Schmid, Jean-Paul, Corrà, Ugo, Agostoni, Piergiuseppe, Dickstein, Kenneth, Seferović, Petar M, Adamopoulos, Stamatis, Ponikowski, Piotr P

“…Abstract Accessibility to the available traditional forms of cardiac rehabilitation programmes in heart failure patients is not adequate and adherence to the…”
Get full text

Heart failure with preserved ejection fraction in Asia: the far side of the moon? by Senni, Michele, Iorio, Annamaria, Seferović, Petar

Get full text

Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy by Seferović, Petar M., Tsutsui, Hiroyuki, Mcnamara, Dennis M., Ristić, Arsen D., Basso, Cristina, Bozkurt, Biykem, Cooper, Leslie T., Filippatos, Gerasimos, Ide, Tomomi, Inomata, Takayuki, Klingel, Karin, Linhart, Aleš, lyon, Alexander R., Mehra, Mandeep R., Polovina, Marija, Milinković, Ivan, Nakamura, Kazufumi, Anker, Stefan D., Veljić, Ivana, Ohtani, Tomohito, Okumura, Takahiro, Thum, Thomas, Tschöpe, Carsten, Rosano, Giuseppe, Coats, Andrew J.S., Starling, Randall C.

“…Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant rejection. In addition, EMB can have an…”
Get full text